Lipid mediator class switching during acute inflammation: signals in resolution
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Leukotrienes (LTs) and prostaglandins (PGs) amplify acute inflammation, whereas lipoxins (LXs) have unique anti-inflammatory actions. Temporal analyses of these eicosanoids in clinical and experimental exudates showed early coordinate appearance of LT and PG with polymorphonuclear neutrophil (PMN) recruitment. This was followed by LX biosynthesis, which was concurrent with spontaneous resolution. Human peripheral blood PMNs exposed to PGE2 (as in exudates) switched eicosanoid biosynthesis from predominantly LTB4 and 5-lipoxygenase (5-LO)-initiated pathways to LXA4, a 15-LO product that "stopped" PMN infiltration. These results indicate that first-phase eicosanoids promote a shift to anti-inflammatory lipids: functionally distinct lipid-mediator profiles switch during acute exudate formation to "reprogram" the exudate PMNs to promote resolution.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Prostaglandin E2 (PGE2) and D2 rapidly initiate the resolution process by inducing the expression of lipid mediators with both anti-inflammatory and pre-resolution functions, e.g., lipoxins [96, 97], resolvins and protectins [98–100], a process known as lipid-mediator class switch [97].”
From Transition from inflammation to proliferation: a critical step during wound healing (2016) · cites this paper as [97]
Citations
Cites
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Inducible cyclooxygenase may have anti-inflammatory properties
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., & Willoughby, D. A. (1999) · Nature Medicine · doi:10.1038/9550 · Cited by 1,242
Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Shinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Swan, S. K., Rudy, D. W., Lasseter, K. C., Ryan, C. F., Buechel, K. L., Lambrecht, L. J., Pinto, M. B., Dilzer, S. C., Obrda, O., Sundblad, K. J., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-1-200007040-00002 · Cited by 339
Design of Lipoxin A4 Stable Analogs That Block Transmigration and Adhesion of Human Neutrophils
Serhan, C. N., Maddox, J. F., Petasis, N. A., Akritopoulou-Zanze, I., Papayianni, A., Brady, H. R., Colgan, S. P., & Madara, J. L. (1995) · Biochemistry · doi:10.1021/bi00044a041 · Cited by 327
Self-citationActivation of the NF-κB Pathway by Inflammatory Stimuli in Human Neutrophils
McDonald, P. P., Bald, A., & Cassatella, M. A. (1997) · Blood · doi:10.1182/blood.v89.9.3421 · Cited by 324
Prostaglandins, Aspirin-like Drugs and the Oedema of Inflammation
MONCADA, S., FERREIRA, S. H., & VANE, J. R. (1973) · Nature · doi:10.1038/246217a0 · Cited by 312 · cited 1×
“Although PGE 2 induces reactions that mediate several of the cardinal features of inflammation (for example, edem”
BackgroundTessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S., & McColl, S. R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3595 · Cited by 233
Research works printed but not linked: 2
- Light, R. W. Pleural Diseases (Lea & Febiger, Philadelphia, 1990).
- Clish, C. B. et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl Acad Sci USA 96, 8247–8252 (1999). · DOI · Paper page
Cited by
Items 401–500 of 1,000
Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells
Markworth, J. F., Brown, L. A., Lim, E. Y., Floyd, C., Larouche, J. A., Castor‐Macias, J. A., Sugg, K. B., Sarver, D. C., Macpherson, P. C. D., Davis, C. S., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.137713 · Cited by 85
“the resolution phase of inflammation, inducing transcription of 15-LOX (33).”
BackgroundMaresin-1 and Inflammatory Disease
Saito‐Sasaki, N., Sawada, Y., & Nakamura, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031367 · Cited by 86
Bhavsar, P. K., Levy, B. D., Hew, M. J., Pfeffer, M. A., Kazani, S., Israel, E., & Fan Chung, K. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-71 · Cited by 74
“Both PGE2 and 15-HETE can play pivotal roles in establishing LX biosynthesis [27,28].”
BackgroundSelf-citationLipids as bioeffectors in the immune system
Cabral, G. A. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.013 · Cited by 85
Aging is characterized by a profound reduction in anti-inflammatory lipoxin A4 levels
Gangemi, S., Pescara, L., D'Urbano, E., Basile, G., Nicita-Mauro, V., Davì, G., & Romano, M. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.04.004 · Cited by 74
Serhan, C. N., & Chiang, N. (2002) · The Scientific World JOURNAL · doi:10.1100/tsw.2002.81 · Cited by 79
“Moreover, both the temporal and spacial components in LX formation and actions are important determinants in their bioimpact during an acute inflammatory reaction[91].”
BackgroundSelf-citationAtf3 negatively regulates Ptgs2/Cox2 expression during acute inflammation
Hellmann, J., Tang, Y., Zhang, M. J., Hai, T., Bhatnagar, A., Srivastava, S., & Spite, M. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.01.001 · Cited by 74
“Their levels decline rapidly as inflammation begins to resolve; a phase that is regulated by distinct families of lipid mediators that terminate leukocyte trafficking and promote macrophage-mediated clearance of apoptotic cells [30, 31].”
BackgroundGavins, F. N. E., Hughes, E. L., Buss, N. A. P. S., Holloway, P. M., Getting, S. J., & Buckingham, J. C. (2012) · The FASEB Journal · doi:10.1096/fj.12-205971 · Cited by 74
“Proinflammatory cytokines also activate microglial cells within the brain parenchyma (4), which stimulates further cytokine release (5) and initiates a vicious circle of cerebral inflammation (6).”
BackgroundL ipoxins in C hronic I nflammation
Kantarcı, A., & Dyke, T. E. V. (2003) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130301400102 · Cited by 77
“Lipoxin generation is a very rapid process that is activated by inflammation, atherosclerosis, and thrombosis (Levy et al., 2001).”
BackgroundParadigm Shift in the Pharmacological Management of Periodontal Diseases
Hasturk, H., Kantarci, A., & Van Dyke, T. E. (2012) · Frontiers of Oral Biology · doi:10.1159/000329678 · Cited by 73
Ang, S.-F., Sio, S. W. S., Moochhala, S., MacAry, P. A., & Bhatia, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101559 · Cited by 73
“Furthermore, COX-2–derived PGE2 is known to mediate the formation of lipoxins, a family of potent anti-inflammatory lipid mediators, in the late phase of acute inflammation (55, 56).”
BackgroundLipoxins Inhibit Akt/PKB Activation and Cell Cycle Progression in Human Mesangial Cells
Mitchell, D., Rodgers, K., Hanly, J. A., McMahon, B. A., Brady, H. R., Martin, F., & Godson, C. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63181-1 · Cited by 75
“It is increasingly appreciated that there are two distinct phases of lipid mediator production in inflammation, an initial phase characterized by the production of proinflammatory mediators essential to effective host defense, which is superseded by the production of anti-inflammatory mediators such as LX during the r…”
BackgroundEmerging cellular functions of the lipid metabolizing enzyme 15‐Lipoxygenase‐1
Çolakoğlu, M., Tunçer, S., & Banerjee, S. (2018) · Cell Proliferation · doi:10.1111/cpr.12472 · Cited by 76
Martin, T. D., Chan, S. S. M., & Hart, A. R. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3437-3 · Cited by 80
“Prostaglandin E2 (PGE2) has anti-inflammatory effects mediated by inhibiting TNF-a, IL-1, 5-lipooxygenase and leukotrienes [47, 48].”
van der Hoeven, D., Wan, T. C., & Auchampach, J. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.048066 · Cited by 77
“N6-(4-Amino-3-[125I]iodobenzyl)adenosine-5 -N-methylcarboxamide ([125I]I-AB-MECA) and 125I-ZM 241385 were synthesized and purified by high-performance liquid chromatography, as described previously (Olah et al., 1994; Palmer et al., 1995).”
BackgroundMethod12/15-Lipoxygenase during the regulation of inflammation, immunity, and self-tolerance
Uderhardt, S., & Krönke, G. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0954-4 · Cited by 78
Specialized Pro-Resolving Lipid Mediators Regulate Ozone-Induced Pulmonary and Systemic Inflammation
Kilburg-Basnyat, B. J., Reece, S. W., Crouch, M. J., Luo, B., Boone, A. D., Yaeger, M. J., Hodge, M. X., Psaltis, C. E., Hannan, J. L., Manke, J., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy040 · Cited by 73
“During resolution of inflammation, pulmonary lipid metabolism shifts to the production of specialized pro-resolving mediators (SPMs) (Levy et al., 2001).”
BackgroundKörner, A., Zhou, E., Müller, C., Mohammed, Y., Herceg, S., Bracher, F., Rensen, P. C. N., Wang, Y., Mirakaj, V., & Giera, M. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911992116 · Cited by 77
Emre, C., Do, K. V., Jun, B., Hjorth, E., Alcalde, S. G., Kautzmann, M.-A. I., Gordon, W. C., Nilsson, P., Bazan, N. G., & Schultzberg, M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01216-4 · Cited by 70
“PC = phosphatidylcholine, PE = phosphatidylethanolamine, PS = phosphatidylserine, SM = sphingomyelin, AA = arachidonic acid, DHA = docosahexaenoic acid, EPA = eicosapentaenoic acid, p‑cPLA2 = phosphorylated (ser505) cytosolic phospholipase 2 (m/z = 782) accumulated more in the aging App KI animal as opposed to WT (Fig.”
BackgroundInfluentialProresolving lipid mediators: potential for prevention and treatment of periodontitis
Dyke, T. E. V. (2011) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01662.x · Cited by 81
Chan, S. S. M., Luben, R., Bergmann, M. M., Boeing, H., Olsen, A., Tjonneland, A., Overvad, K., Kaaks, R., Kennedy, H., Khaw, K.-T., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04784.x · Cited by 70
Inflamm-Aging and Arachadonic Acid Metabolite Differences with Stage of Tendon Disease
Dakin, S. G., Dudhia, J., Werling, N. J., Werling, D., Abayasekara, D. R. E., & Smith, R. K. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048978 · Cited by 70
“These recently discovered pathways demonstrate critical roles in the switching of lipid mediators from the prostaglandin to the lipoxin axis, returning injured tissues to their previous state [49] by depleting PGE2 levels due to reduced arachadonic acid substrate availability.”
Background5-Lipoxygenase: Underappreciated Role of a Pro-Inflammatory Enzyme in Tumorigenesis
Steinhilber, D., Kahnt, A. S., Metzner, J., Steinbrink, S. D., Roos, J., Ruthardt, M., & Maier, T. J. (2010) · Frontiers in Pharmacology · doi:10.3389/fphar.2010.00143 · Cited by 72
“Furthermore, the lipoxins are formed by the cooperative action of 5- and 15-LO on AA (Serhan et al., 1984) and are involved in programmed resolution of acute inflammation (Levy et al., 2001).”
Background15-Lipoxygenase-1 as a tumor suppressor gene in colon cancer: is the verdict in?
Lee, S. I., Zuo, X., & Shureiqi, I. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9321-0 · Cited by 72
“As mentioned earlier in this article, 15-LOX-1 is critical to the formation of the lipoxins, which promote inflammation resolution [30], and 15-LOX-1 is a major enzyme catalyzing the conversion of n-3 PUFAs to the powerful anti-inflammatory products RvDs and PDs [14– 16].”
Ungaro, F., Rubbino, F., Danese, S., & D’Alessio, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01331 · Cited by 79
“LXs deriving from the metabolic route of AA, have been shown to inhibit PMN flux across the epithelial barrier (21, 72).”
BackgroundNeutrophils: Innate Effectors of TB Resistance?
Kroon, E. E., Coussens, A. K., Kinnear, C. J., Orlova, M., Möller, M., Seeger, A., Wilkinson, R. J., Hoal, E. G., & Schurr, E. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02637 · Cited by 86
“LXA4 decreases neutrophil-mediated tissue damage, neutrophil proliferation, and adhesion, and increases efferocytosis of apoptotic neutrophils and IL-10 production by macrophages (159).”
BackgroundSpecialized pro‐resolving mediators: biosynthesis and biological role in bacterial infections
Jordan, P. M., & Werz, O. (2021) · FEBS Journal · doi:10.1111/febs.16266 · Cited by 79
Human CYP2S1 Metabolizes Cyclooxygenase- and Lipoxygenase-Derived Eicosanoids
Bui, P. H., Imaizumi, S., Beedanagari, S. R., Reddy, S. T., & Hankinson, O. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035121 · Cited by 68
“The fatty acid hydroperoxides are intermediate precursors of many important inflammatory compounds, such as the leukotrienes (proinflammatory) and lipoxins (anti-inflammatory) (Levy et al., 2001; Nebert and Karp, 2008).”
BackgroundTherapeutic potential of resolvins in the prevention and treatment of inflammatory disorders
Lee, H., & Surh, Y. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.004 · Cited by 79
Rodgers, K., McMahon, B. A., Mitchell, D., Sadlier, D. M., & Godson, C. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62043-3 · Cited by 74
CRAC channel regulation of innate immune cells in health and disease
Clemens, R. A., & Lowell, C. A. (2019) · Cell Calcium · doi:10.1016/j.ceca.2019.01.003 · Cited by 71
Körner, A., Schlegel, M., Kaussen, T., Gudernatsch, V., Hansmann, G., Schumacher, T., Giera, M. A., & Mirakaj, V. (2019) · Nature Communications · doi:10.1038/s41467-019-08328-5 · Cited by 71
Muqaku, B., Pils, D., Mader, J. C., Aust, S., Mangold, A., Muqaku, L., Slany, A., Favero, G. D., & Gerner, C. (2020) · Cancers · doi:10.3390/cancers12020505 · Cited by 68
“The COX-product PGE2 (Figure 1B) is actually known to further promote eicosanoid class switching in neutrophils initiating a feed-back loop [22,35].”
BackgroundDamage-mediated macrophage polarization in sterile inflammation
Koncz, G., Jenei, V., Tóth, M., Váradi, E., Kardos, B., Bácsi, A., & Mázló, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1169560 · Cited by 82
“PGE2 plays a role in early inflammatory events, but the second wave of its production typically induces an anti-inflammatory process (74).”
BackgroundEndogenous LXA4 Circuits Are Determinants of Pathological Angiogenesis in Response to Chronic Injury
Leedom, A. J., Sullivan, A. B., Dong, B., Lau, D., & Gronert, K. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090678 · Cited by 69
Self-citationNeutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections
Jose, S., & Madan, R. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.04.001 · Cited by 77
“214 In bacterial infections of the gut, neutrophils are involved in healing and restoring tissue 215 integrity by phagocytosis of pathogens and cell debris [75], secretion of factors that 216 enhance mucosal healing [76] and by secreting anti-inflammatory molecules [77] that 217 inhibit further neutrophil recruitment…”
Dalli, J. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.03.007 · Cited by 67
Resolution of Inflammation in Periodontitis
Kantarcı, A., & Dyke, T. E. V. (2005) · Journal of Periodontology · doi:10.1902/jop.2005.76.11-s.2168 · Cited by 77
Hori, T., Yokomizo, T., Ago, H., Sugahara, M., Ueno, G., Yamamoto, M., Kumasaka, T., Shimizu, T., & Miyano, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312655200 · Cited by 68
Therapeutic potential of pro-resolving mediators in diabetic kidney disease
Vartak, T., Godson, C., & Brennan, E. P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113965 · Cited by 72
Gravaghi, C., Perle, K. M. D. L., Ogrodwski, P., Kang, J. X., Quimby, F. W., Lipkin, M., & Lamprecht, S. A. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.03.003 · Cited by 67
“[34].”
Antiinflammatory cAMP signaling and cell migration genes co-opted by the anthrax bacillus
Kim, C., Wilcox-Adelman, S., Sano, Y., Tang, W.-J., Collier, R. J., & Park, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800105105 · Cited by 67
“Besides its well understood proinflammatory functions, COX-2, the inducible isoform of the enzyme, was recently found to perform key antiinflammatory functions through PGE2 and possibly other PG products in tissues undergoing inflammatory resolution (23, 24).”
BackgroundRegidor, P., Mueller, A., Sailer, M., Santos, F. G., Rizo, J. M., & Egea, F. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010384 · Cited by 77
“Conseque tly, th inhibition of PG-synthesis impedes the class switching of lipid mediators and may delay resolution [31,32].”
BackgroundYang, M.-S., Ji, K.-A., Jeon, S.-B., Jin, B.-K., Kim, S. U., Jou, I., & Joe, E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1323 · Cited by 66
“PGE2 increases levels of anti-inflammatory lipid mediators, such as lipoxins (30, 37).”
BackgroundChaitidis, P., O’Donnell, V. B., Kuban, R. ‐., Bermúdez-Fajardo, A., Ungethuem, U., & Kühn, H. (2005) · Cytokine · doi:10.1016/j.cyto.2005.02.004 · Cited by 80
“15-LOX1 has been identified as anti-inflammatory enzyme in various in vivo inflammation models [36,37] and this activity may be related to its involvement in the biosynthesis of lipoxins [38,39].”
BackgroundSerhan, C. N. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.09.016 · Cited by 71
Self-citationResolution of Adipose Tissue Inflammation
González‐Périz, A., & Clària, J. (2010) · The Scientific World JOURNAL · doi:10.1100/tsw.2010.77 · Cited by 78
“However, the same factors that initially trigger the inflammatory response also signal the termination of inflammation by stimulating the biosynthesis of proresolving lipid mediators[92,93].”
BackgroundInfluentialGuan, S., Jia, B., Chao, K., Zhu, X., Tang, J., Li, M., Wu, L., Xing, L., Liu, K., Zhang, L., et al. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00440 · Cited by 65
Fredenburgh, L. E., Velandia, M. M. S., Ma, J., Olszak, T., Cernadas, M., Englert, J. A., Chung, S. W., Liu, X., Begay, C., Padera, R. F., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101186 · Cited by 75
“COX-2– derived prostanoids mediate acute inflammation by increasing vascular permeability and recruiting inflammatory cells to sites of infection; however, these mediators are also key regulators in the resolution of inflammation (5).”
Schwab, J. M., Schluesener, H. J., Meyermann, R., & Serhan, C. N. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.07.003 · Cited by 92
“Also, PGE2 and PGD2 produced early within inflammation stimulates a class swift in eicosanoids profiles by inducing the appearance of 15-lipoxygenase that contribute to lipoxin formation during resolution [19].”
BackgroundSelf-citationDo patients benefit from omega-3 fatty acids?
Sherratt, S. C. R., Mason, R. P., Libby, P., Steg, P. G., & Bhatt, D. L. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad188 · Cited by 80
“110 The precursor O3FA and O6FAs in the cell membrane are hydrolyzed from the phospholipid via phospholipase A2 (PLA2) to elicit various downstream cellular responses through their distinct bioactive lipid metabolites generated from intracellular cyclooxygenases (COXs), lipoxy-genases (LOXs), and…”
BackgroundPezeshki, A., Stordeur, P., Wallemacq, H., Schynts, F., Stevens, M. G. H., Boutet, P., Peelman, L. J., Spiegeleer, B. M. J. D., Duchateau, L., Bureau, F., et al. (2011) · Veterinary Research · doi:10.1186/1297-9716-42-15 · Cited by 85
“LTB4 is known to induce infiltration and sequestration of the neutrophils in the bovine mammary gland, whereas LXA4 serve as neutrophil “stop signals” in inflammation [12].”
BackgroundNalini, N., Aranganathan, S., & Kabalimurthy, J. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.673092 · Cited by 64
“COX-2 expression is induced in inflammatory and malignant conditions by several stimuli including proinflammatory cytokines and mutagenic substances, followed by uncontrolled colonic epithelial cell proliferation (Levy et al. 2001).”
BackgroundPrescott, D., & McKay, D. M. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00042.2011 · Cited by 64
“Although the kinetics and dynamics of lipoxin-driven resolution of inflammation in sterile compartments such as the dorsal air pouch (32) have been characterized, much less is known about the role of lipoxins in the resolution of inflammation that is driven by live bacteria.”
BackgroundLipoxin A4 inhibits IL-1β-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells
Decker, Y., McBean, G. J., & Godson, C. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00380.2008 · Cited by 67
“The signaling pathway leading to the synthesis of pro-inflammatory eicosanoid-derived lipids such as the prostaglandins PGE2 and PGD2 is switched to the production of enzymes that are necessary for the synthesis of lipoxins (24).”
BackgroundChattopadhyay, R., Raghavan, S., & Rao, G. N. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.023 · Cited by 67
“Many inflammatory diseases arise due to uncontrolled inflammatory response or in other words failure of resolution process [1,2].”
BackgroundResolvin E1 Promotes Bone Preservation Under Inflammatory Conditions
Kholy, K. E., Freire, M., Chen, T., & Dyke, T. E. V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01300 · Cited by 73
Serhan, C. N., de la Rosa, X., & Jouvene, C. C. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12871 · Cited by 70
Self-citationNevius, E., Srivastava, P. K., & Basu, S. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.50 · Cited by 65
Das, U. N. (2010) · Journal of Inflammation Research · doi:10.2147/jir.s9425 · Cited by 64
“During the early phase of inflammation, COX-derived PGs and lipoxygenase-derived LTs initiate exudate formation and inflammatory cell influx.(8) TNF-α causes an immediate influx of neutrophils concomitant with PGE 2 and LTB 4 production, whereas during the phase of resolution of inflammation an increase in LXA 4”
Syeda, M. M., Jing, X., Mirza, R. H., Yu, H., Sellers, R. S., & Chi, Y. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.03.012 · Cited by 68
Resolvin D1 protects periodontal ligament
Mustafa, M., Zarrough, A., Bolstad, A. I., Lygre, H., Mustafa, K., Hasturk, H., Serhan, C., Kantarci, A., & Van Dyke, T. E. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00242.2012 · Cited by 63
“, neutrophils and mononuclear phagocytes) in the exudate to initiate resolution (28, 38).”
BackgroundSelf-citationLaan, L. C., Williams, A. R., Stavenhagen, K., Giera, M., Kooij, G., Vlasakov, I., Kalay, H., Kringel, H., Nejsum, P., Thamsborg, S. M., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600841r · Cited by 63
“PGE2 produced early in the inflammatory response activates enzymes that drive the production of pro-resolving lipid mediators in the resolution phase, a process defined as lipid-mediator class switching (34).”
BackgroundWu, B., Mottola, G., Schaller, M. S., Upchurch, G. R., & Conte, M. S. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.07.005 · Cited by 72
“…pathways for both omega-3 and omega-6 fatty acids are complex and involve competition for enzymes to production various bioactive mediators (Levy et al., 2001; Serhan, 2007; Spite and Serhan, 2010; Merched et al., 2011; Colas et al., 2014; Serhan, 2014; Poorani et al., 2016) and this…”
BackgroundMaintaining a protective state for human periodontal tissue
Yamamoto, M., & Aizawa, R. (2021) · Periodontology 2000 · doi:10.1111/prd.12367 · Cited by 77
Lumbroso, D., Soboh, S., Maimon, A., Schif‐Zuck, S., Ariel, A., & Burstyn‐Cohen, T. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00358 · Cited by 74
Martel‐Pelletier, J., Mineau, F., Fahmi, H., Laufer, S., Reboul, P., Boileau, C., Lavigne, M. J. F., & Pelletier, J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20632 · Cited by 63
Qiu, F.-H., Devchand, P. R., Wada, K., & Serhan, C. N. (2001) · The FASEB Journal · doi:10.1096/fj.01-0576fje · Cited by 63
“eicosanoid profiles, in which switching to protective eicosanoids such as lipoxins correlates with the onset of resolution of the acute inflammatory reaction (3).”
BackgroundSelf-citationMoffett, J., Kubat, N. J., & Fray, L. M. (2015) · Journal of Inflammation Research · doi:10.2147/jir.s78631 · Cited by 68
“PEMF treatment was followed by an increase in mRNA levels of interleukin 12B in HDF and HMNC, while mRNA levels of interleukins 20 and 21 were upregulated only in HEK and HMNC relative to untreated control cells (Figure 6 and Table 2).”
Can inflammation be resolved in Alzheimer’s disease?
Zhu, M., Wang, X., Sun, L., Schultzberg, M., & Hjorth, E. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418791107 · Cited by 62
Kowal‐Bielecka, O., Kowal, K., Distler, O., Rojewska, J., Bodzenta‐Łukaszyk, A., Michel, B. A., Gay, R. E., Gay, S., & Sierakowski, S. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21432 · Cited by 62
Lipoxygenase Pathways as Mediators of Early Inflammatory Events in Atherosclerosis
Funk, C. D. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000222960.43792.ff · Cited by 70
Perretti, M., & Dalli, J. (2022) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051821-042743 · Cited by 69
Physical exercise increases urinary excretion of lipoxin A 4 and related compounds
Gangemi, S., Luciotti, G., D’Urbano, E., Mallamace, A., Santoro, D., Bellinghieri, G., Davì, G., & Romano, M. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01004.2002 · Cited by 67
“LX function as stop signals during inflammation, and their role in the resolution of the inflammatory response has been recently elucidated (10).”
BackgroundZhang, G., Liu, X., Wang, W., Cai, Y., Shao-yuan, L., Chen, Q., Liao, M., Zhang, M., Zeng, G., Zhou, B., et al. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1215386 · Cited by 63
“as H37Ra induce PGE2 production, which initiates protection of the mitochondria from bacteria-induced damage and promotes apoptosis, while virulent Mtb inhibits plasma membrane repair based on its ability to block PGE2 synthesis.(48,49) The elucidation of molecular mechanisms by which macrophages regulate apoptosis du…”
BackgroundDalli, J., Kraft, B. D., Colas, R. A., Shinohara, M., Fredenburgh, L. E., HESS, D. R., Chiang, N., Welty‐Wolf, K. E., Choi, A. M. K., Piantadosi, C. A., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2014-0299oc · Cited by 64
“If the inflammation is self-limited, leukocytes undergo LM class switching and produce specialized proresolving mediators (SPMs) (13), a recently discovered genus of LMs that actively promote resolution of inflammation (12, 14).”
BackgroundSelf-citationMariani, F., Sena, P., Marzona, L., Riccio, M., Fano, R. A., Manni, P., Gregorio, C. D., Pezzi, A., de Leòn, M. P., Monni, S., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.02.001 · Cited by 65
“COX-2 expression is induced in inflammatory and malignant conditions by several stimuli including proinflammatory cytokines and mutagenic substances, followed by uncontrolled colonic epithelial cell proliferation [7].”
BackgroundImmune-Mediated Repair: A Matter of Plasticity
Laurent, P., Jolivel, V., Manicki, P., Chiu, L., Contin‐Bordes, C., Truchetet, M., & Pradeu, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00454 · Cited by 73
Lipid Autacoids in Inflammation and Injury Responses: A Matter of Privilege
Gronert, K. (2008) · Molecular Interventions · doi:10.1124/mi.8.1.7 · Cited by 60
Self-citationSampaio, S. C., Alba‐Loureiro, T. C., Brigatte, P., Landgraf, R. G., dos Santos, É. C., Curi, R., & Cury, Y. (2005) · Toxicon · doi:10.1016/j.toxicon.2005.11.008 · Cited by 64
“Redox lipidomics technology: Looking for a needle in a haystack”
Tyurina, Y. Y., Tyurin, V. A., Anthonymuthu, T., Amoscato, A. A., Sparvero, L. J., Nesterova, A. M., Baynard, M. L., Sun, W., He, R., Khaitovich, P., et al. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.03.012 · Cited by 58
Immunometabolism in biofilm infection: lessons from cancer
Mirzaei, R., Sabokroo, N., Ahmadyousefi, Y., Motamedi, H., & Karampoor, S. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00435-2 · Cited by 63
“For example, following viral infection, infected cells instantly discharge type I IFNs (IFN-α and/or β) that stimulate initial viral defense strategies and are also crucial for polarization of the immune system towards antiviral Th1 response (Levy et al. 2001; Proietti et al. 2002; Abdi and Mirzaei 2020).”
BackgroundThe immunology of sepsis: translating new insights into clinical practice
Kox, M., Bauer, M. W., Bos, L. D. J., Bouma, H. R., Calandra, T., Calfee, C. S., Chousterman, B. G., Derde, L. P. G., Giamarellos‐Bourboulis, E. J., Gómez, H., et al. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01004-6 · Cited by 95
“These mediators inhibit neutrophil infiltration, enhance clearance of apoptotic cells (via efferocytosis) and stimulate macrophage polarization 98–101 .”
Planagumà, A., Titos, E., López‐Parra, M., Gaya, J., Pueyo, G., Arroyo, V., & Clària, J. (2002) · The FASEB Journal · doi:10.1096/fj.02-0224fje · Cited by 59
“(28), the increase in LTB4 formation following ASA treatment may be secondary to abolishment of the inhibitory action exerted by COX-derived products (including PGE2) on LTB4 biosynthesis.”
BackgroundElias, I., Ferré, T., Vilà, L., Muñoz, S., Casellas, A., Garcia, M., Molas, M., Agudo, J., Roca, C., Ruberte, J., et al. (2016) · Diabetes · doi:10.2337/db16-0040 · Cited by 59
Kawano, Y., Fukui, C., Shinohara, M., Wakahashi, K., Ishii, S., Suzuki, T., Sato, M. M., Asada, N., Kawano, H., Minagawa, K., et al. (2016) · Blood · doi:10.1182/blood-2016-07-725754 · Cited by 68
Dermal Fibroblasts Promote Alternative Macrophage Activation Improving Impaired Wound Healing
Ferrer, R. A., Saalbach, A., Grünwedel, M., Lohmann, N., Forstreuter, I., Saupe, S., Wandel, E., Simon, J. C., & Franz, S. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.11.035 · Cited by 68
Inflammation, Lipid (Per)oxidation, and Redox Regulation
Dias, I. H. K., Milic, I., Heiß, C., Ademowo, O. S., Polidori, M. C., Devitt, A., & Griffiths, H. R. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8022 · Cited by 64
Kotlyarov, S. N., & Котлярова, А. А. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312803 · Cited by 64
“Prostaglandin (PGE2) then promotes the switch of biosynthesis from LTB4 involving 5-lipoxygenase (5-LO), to LXA4 involving 15-LO, which leads to a decrease in tissue infiltration by neutrophils [66,67].”
BackgroundHua, J., Jin, Y., Chen, Y., Inomata, T., Lee, H., Chauhan, S. K., Petasis, N. A., Serhan, C. N., & Dana, R. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-14356 · Cited by 61
Self-citationAnti-inflammatory mediators as physiological and pharmacological regulators of parturition
Rinaldi, S. F., Hutchinson, J. L., Rossi, A. G., & Norman, J. E. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.58 · Cited by 66
Clinical chorioamnionitis at term: the amniotic fluid fatty acyl lipidome
Maddipati, K. R., Romero, R. J., Chaiworapongsa, T., Chaemsaithong, P., Zhou, S.-L., Xu, Z., Tarca, A. L., Kusanovic, J. P., Gómez, R., Docheva, N., et al. (2016) · Journal of Lipid Research · doi:10.1194/jlr.p069096 · Cited by 59
“Such lipid mediator class switching is crucial to limit inflammation to a homeostatic function and prevent a chronic inflammatory response (28).”
BackgroundBenson, M., Carlsson, L. M. S., Adner, M., Jernås, M., Rudemo, M., Sjögren, A., Svensson, P., Uddman, R., & Cardell, L. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.02.028 · Cited by 60
Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils
Komarnytsky, S., Thirumurugan, R., Wagner, C., Metzger, B. T., Carlisle, C., Panda, C., Brun-Blashka, S. L., TROUP, J. P., & Varadharaj, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115479 · Cited by 66
“The transition from arachidonate-derived eicosanoids that drive inflammation (prostaglandins and leukotrienes) to anti-inflammatory lipoxins (such as LXA4) is driven in part by prostaglandins E2 and D2 that regulate the transcription of enzymes involved in lipoxin biosynthesis that complete the inflammatory feedback l…”
BackgroundPonce, J., Ulu, A., Hanson, C., Cameron‐Smith, E., Bertoni, J. M., Wuebker, J., Fisher, A. L., Siu, K., Marmelat, V., Adamec, J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.780811 · Cited by 60
Lipoxin Mimetics and the Resolution of Inflammation
Godson, C., Guiry, P. J., & Brennan, E. P. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-085407 · Cited by 61
Hsiao, H.-M., Thatcher, T. H., Levy, E. P., Fulton, R. A., Owens, K. M., Phipps, R. P., & Sime, P. J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400313 · Cited by 60
Magdalon, J., Vinolo, M. A. R., Rodrigues, H. G., Paschoal, V. A., Torres, R. P., Mancini‐Filho, J., Calder, P. C., Hatanaka, E., & Curi, R. (2012) · Lipids · doi:10.1007/s11745-012-3687-9 · Cited by 65
“acid and also play a central role in the inflammatory response such that those that are synthesized during the beginning of inflammation are gradually switched to others with anti-inflammatory and inflammation-resolving properties [40].”
BackgroundLipids as targets for novel anti-inflammatory therapies
Huwiler, A., & Pfeilschifter, J. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.008 · Cited by 74
Rieger, A. M., Konowalchuk, J. D., Grayfer, L., Katzenback, B. A., Havixbeck, J. J., Kiemele, M. D., Belosevic, M., & Barreda, D. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047070 · Cited by 61
“feature that signals the start to the resolution of inflammation [59].”
Background
Metadata
- Authors
- Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K., & Serhan, C. N.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Serhan, Charles N.
- Venue
- Nature Immunology
- Published
- 2001-07
- Volume
- 2
- Issue
- 7
- Pages
- 612-619
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1497700962
- Cited by
- 1,453
- References
- 42
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 61 · 2023: 74 · 2022: 74 · 2021: 81 · 2020: 76 · 2019: 64 · 2018: 69 · 2017: 62 · 2016: 62 · 2015: 63 · 2014: 62 · 2013: 69 · 2012: 60
- FWCI
- 33.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl003788-04)
- National Heart, Lung, and Blood Institute (K08 HL 03788)
- National Institute of General Medical Sciences (GM 38765)
- National Institute of Allergy and Infectious Diseases (F32AI010389, F32-AI10389)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-50305, P01DK050305, K01DK060583)
- National Institute of Dental and Craniofacial Research (P01 DE 13499, P01DE013499)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- lipid mediators, acute inflammation, inflammation resolution, leukotrienes, prostaglandins, lipoxins, eicosanoid biosynthesis, neutrophil recruitment, lipoxin A4, leukotriene B4, 5-lipoxygenase, 15-lipoxygenase, prostaglandin E2, exudate, anti-inflammatory signaling
- MeSH terms
- Animals, Arachidonate 15-Lipoxygenase, Base Sequence, Humans, Hydroxyeicosatetraenoic Acids, Leukotriene B4, Lipids, Male, Mice, Inbred BALB C, Molecular Sequence Data, Neutrophils, Pleural Effusion, RNA, Messenger, Dinoprostone, Molecular Structure, Signal Transduction, DNA, Complementary, Lipoxins, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.